
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Occupational Health Program, Department of Environmental Health, Harvard School of Public Health, Boston, MA; 2 Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; 3 Ames Laboratory, U.S. Department of Energy, Department of Chemistry, Iowa State University, Ames, IA; 4 Environmental Health Program, Department of Civil and Environmental Engineering, Tufts University, Medford, MA; and 5 Massachusetts General Hospital and Harvard Medical School, Boston, MA
Requests for reprints: David C. Christiani, Occupational Health Program, Department of Environmental Health, Harvard School of Public Health, Building I, Room 1402, 665 Huntington Avenue, Boston, MA 02115. Phone: (617) 432-3323; Fax: (617) 432-3441. E-mail: dchris{at}hohp.harvard.edu
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The molecular and cellular mechanisms leading to tumor formation after exposure to PAH and metals are poorly understood (14). However, it has been shown that particle-induced inflammation in the lungs causes macrophages to release reactive oxygen species (ROS), and transition metals on the particle surface can generate ROS through the Fenton reaction and lead to the formation of oxidative DNA lesions (14, 15). The development of such oxidative DNA damage coupled with interference to DNA repair processes is likely to play an important role in the development of cancer (16).
The most widely studied biomarker of oxidative DNA damage is 8-hydroxy-2'-deoxyguanosine (8-OH-dG). 8-OH-dG is a particular type of ROS-induced DNA base modification (i.e., the C8 hydroxylation of deoxyguanosine). 8-OH-dG is premutagenic because it can mispair with adenine instead of cytosine during DNA replication, and if this occurs, a G
T transversion mutation develops. The repair mechanism for DNA after 8-OH-dG is incorporated into DNA involves base and nucleotide excision with DNA-specific nucleosides excreted into urine (17). Therefore, the measurement of urinary 8-OH-dG can be used as an overall estimate of repaired oxidative DNA damage within an individual (18).
The aim of this study was to investigate associations between urinary levels of PAH and metal exposure biomarkers and urinary levels of the oxidative injury biomarker, 8-OH-dG. We conducted a repeated-measures cohort study in boilermakers exposed occupationally to a complex chemical mixture of PAH (from ROFA) and metals (through welding and ROFA exposure) during the overhaul of an oil-fired boiler. The well-validated PAH exposure biomarker, 1-OHP, was chosen to determine PAH exposure (19) and six urinary metal exposure biomarkers were selected based on previous work that showed that these metals had the highest concentration in ROFA (11, 20). These were vanadium, chromium, manganese, nickel, copper, and lead. The present study is the first to evaluate the association between such exposure and oxidative injury biomarkers in a population of highly exposed workers.
| Materials and Methods |
|---|
|
|
|---|
Study Population
The study was approved by the Institutional Review Board of Harvard School of Public Health. The study population consisted of 20 boilermakers who were monitored during 5 consecutive days of work. Their hours of work were
7:00 a.m. to 5:00 p.m., with potential exposures to metal fume and ROFA that was present in and around the boiler.
Work Description
The work process has been described previously (13). Briefly, boilermaker construction workers at the power plant were responsible for the repair of sections of the interior wall of the boiler. This involved acetylene torch cutting, carbon stick, and electric arc welding. The occupational exposure to PAH occurred through contact with ROFA that coated the walls of the boiler and accumulated in an ash pit at the base of the boiler after high temperature combustion.
Data Collection
All participants completed a self-administered modified American Thoracic Society questionnaire with specific data collected on past medical history, respiratory symptoms, smoking, and work exposure history. Spot urine samples were collected from each subject preshift and postshift for 5 consecutive days of work leading to a maximum of 10 urine samples from each individual. All urine samples were frozen at -20°C until urinary 1-OHP, 8-OH-dG, and metal laboratory analysis was performed. Urinary creatinine and cotinine were measured for each sample of urine (ESA Laboratories, Inc., Chelmsford, MA). Urinary cotinine was determined using reverse-phase high-performance liquid chromatography (HPLC) with UV absorption detection, and urinary creatinine was measured using spectrophotometry.
Extraction Procedure and Reverse-Phase HPLC Analysis for 1-OHP
The analytical procedure to determine urinary 1-OHP levels by HPLC has been described previously (13, 21, 22). The calculated concentration of urinary 1-OHP was adjusted to the urinary concentration of creatinine (µg 1-OHP/g creatinine) to control for variation in urinary flow.
Urinary Metal Analysis
Calibration solutions were prepared from single-element stock solutions (1000 mg/l; Claritas PPT; SPEX CertiPrep, Metuchen, NJ) and diluted to the desired concentration using 5% high-purity aqueous nitric acid. A blank solution of 5% nitric acid was also prepared. A 1-ml aliquot of each urine sample was mixed with equal volumes of concentrated nitric acid and a stock solution containing 100-ppb scandium as an internal standard. The resultant mixture was diluted to 20 ml using distilled, deionized water.
A Finnigan MAT Element 1 magnetic sector inductively coupled plasma-mass spectrometer(Bremen, Germany) was used for metal analysis (2325). For the quantification experiments described here, the Element was operated in medium resolution mode (R = m/
m = 4000) for all elements, which is sufficient to separate the main polyatomic ions at these m/z values (24, 25). The "shielded" load coil (CD-1 torch, Finnigan MAT) improved sensitivity by a factor of 320 (depending on m/z) while still maintaining the extremely low background and high precision of the double-focusing instrument (26). The instrument was also fitted with platinum-tipped sampler and skimmer cones to reduce the instrument background for nickel.
A Teflon spray chamber and microconcentric nebulizer (Model ES-2002; Elemental Scientific, Inc., Omaha, NE) were used. The sample was drawn up at
100 µl/min by natural suction. The Teflon nebulizer was cleaned on-line by aspiration of 2% aqueous hydrofluoric acid for 15 s before the analysis of each urine sample. This process maintained a low background signal and minimized clogging or loss of uptake by the nebulizer.
Each urine sample was vortexed prior to analysis to insure sample homogeneity. Six metal analytesvanadium, chromium, manganese, nickel, copper, and leadwere determined in each urine sample. The spectrometer measured 20 lines/peak using 50 ms/line for the following seven isotopes: 45Sc, 51V, 52Cr, 55Mn, 60Ni, 63Cu, and 208Pb. Ten spectra were measured and averaged for each urine sample. Each sample was aspirated for 45 s before data acquisition to allow for adequate signal equilibration. The peaks for each analyte were integrated and corrected for blank levels and isotopic abundance. The metal concentrations in the original samples were calculated after adjusting for the internal standard and dilution factor. The following percentage of urine samples had metal concentrations that were below the limit of detection: 3% of all samples for chromium, 17% for manganese, 7% for nickel, 1% for copper, and 9% for lead. The concentration of individual urinary metals was adjusted to the urinary concentration of creatinine (µg metal/g creatinine) to control for variation in urinary flow.
Urinary 8-OH-dG Testing
Urinary 8-OH-dG levels were determined using a competitive ELISA immunoassay (Japan Institute for the Control of Ageing, Fukuroi, Shizuoka, Japan) performed by Genox Corporation (Baltimore, MD) and has been described previously (27, 28). Briefly, 50-µl urine samples and standards were added to precoated 8-OH-dG protein conjugate microtitre plates followed by 50 µl of the primary antibody, anti-8-OH-dG monoclonal antibody solution. After incubation for 1 h at 37°C, the plates were washed and the enzyme-labeled secondary antibody (100 µl) was applied for 1 h at 37°C. After washing, 100 µl of the chromatic substrate, 3,3',5,5'-tetramethylbenzidene, were added to the plate and allowed to react at room temperature for 15 min. The intensity of color produced for each sample was measured at an absorbance of 490 nm. Pooled urine samples from several healthy adults were used as the quality control samples. For each standard 96-well microplate, six to nine quality control samples were randomly placed among the unknown samples. The measured quality control values were averaged and compared with previously established values. Acceptable quality control values were defined as mean ± 2 SDs. The limit of detection for 8-OH-dG was 0.64 ng/ml. For each subject sample, either a duplicate or a triplicate measurement was performed. The mean, SD, and coefficient of variation (%) were calculated and any sample with coefficient of variation (%)
20% was retested. The concentration of urinary 8-OH-dG was adjusted to the urinary concentration of creatinine (µg 8-OH-dG/g creatinine) to control for variation in urinary flow.
Statistical Analysis
Statistical analysis investigated the association of urinary 8-OH-dG levels with the following potential explanatory variables: age, self-reported smoking status, urinary level of metals (vanadium, chromium, manganese, nickel, copper, and lead), individual metal or 1-OHP x cotinine interaction, urinary 1-OHP, urinary cotinine level, day of urine collection, and assignment of daily exposure (i.e., preshift or postshift). Urinary 1-OHP, metal, and cotinine levels were skewed with a long right tail and therefore were loge transformed prior to analysis and were approximately normally distributed after loge transformation. Because there were some samples with zero values in the urinary metal raw data, a constant was added to all values prior to loge transformation. Urinary 8-OH-dG levels were normally distributed. The day of measurement (days 15) and self-reported smoking status were analyzed as categorical covariates. All other variables were analyzed as continuous.
Generalized estimating equations (GEE; 29) were used to investigate the bivariate and multivariate relationships and predictive value of the explanatory variables and covariates of interest with the 8-OH-dG levels at each time point and to appropriately adjust for the within-individual correlations present in these data. Both forward and backward stepwise procedures were used to select a set of independent predictors. The modeling included an investigation of interaction and polynomial terms.
Analysis and data management was carried out using STATA v5 (Stata Corporation, College Station, TX) and SPlus v2000 (Mathsoft, Inc., Cambridge, MA). Formal statistical significance was defined at the conventional 5% level.
| Results |
|---|
|
|
|---|
|
2-fold higher day 1 preshift levels than smokers (P > 0.10), but by day 5 postshift, the levels in both smokers and nonsmokers were comparable. For copper, there was minimal difference in cross-week levels in smokers and nonsmokers. For 1-OHP, smokers had significantly higher levels compared with nonsmokers (0.39 to 0.16 µg/g creatinine, P < 0.03), but nonsmokers exhibited a greater overall increase compared with smokers (0.16 to 0.33 µg/g creatinine). Urinary metal and 1-OHP levels varied markedly between individuals, as reflected by the wide confidence intervals (CI) around each time point, which increased during the week.
|
8 h of work, the day 1 postshift 8-OH-dG level in nonsmokers had decreased by
13% compared with the day 1 preshift level. This decline in the 8-OH-dG level in nonsmokers continued during the next 1214 h, and by day 2 preshift, the urinary 8-OH-dG level in nonsmokers had decreased by
50% from day 1 preshift levels and was similar to levels observed in smokers. From day 2 preshift onwards, the 8-OH-dG levels in smokers and nonsmokers are similar, although there may be a slight increase in 8-OH-dG levels cross-shift for days 35 in nonsmokers.
|
|
Association between Urinary 8-OH-dG and Metal/1-OHP x Cotinine Interactions
Multivariate GEE analysis indicated that vanadium x cotinine, chromium x cotinine, nickel x cotinine, and copper x cotinine interaction terms were significant predictors of the 8-OH-dG level (Table 3, models 1, 2, 4, and 5). All models were also adjusted for age, each individual metal, and loge (cotinine level). The vanadium x cotinine and nickel x cotinine interaction terms were found to be significantly associated with decreased 8-OH-dG levels (Table 3, models 1 and 4); with increasing exposure to tobacco smoke, these metals were associated with a reduction in 8-OH-dG levels. In contrast, chromium x cotinine and copper x cotinine interaction terms were found to be significantly associated with increased 8-OH-dG (Table 3, models 2 and 5); with increasing exposure to tobacco smoke, these metals were associated with an elevation in 8-OH-dG levels. The manganese x cotinine, lead x cotinine, and 1-OHP x cotinine interaction terms were not significantly associated with the 8-OH-dG level (Table 3, models 3, 6, and 7).
| Discussion |
|---|
|
|
|---|
Levels of Urinary Metals and PAH Biomarkers across the Workweek Vary by Smoking Status
In this study, the patterns of increase of exposure biomarkers across the workweek varied by smoking status. For example, for urinary lead and vanadium levels, smokers and nonsmokers had similar levels at the start of the workweek, but nonsmokers developed much higher levels than smokers by the end of the workweek (Table 2). This observation may suggest that nonsmokers had higher levels of occupational exposure than smokers; however, particulate matter (diameter
2.5 µm) levels from filter measurements from this same cohort did not demonstrate a correlation between particulate matter (diameter
2.5 µm) exposure and smoking status (Spearman's rank correlation r = -0.06, P = 0.70; unpublished observations). Alternatively, smokers may have improved clearance mechanisms for lead and vanadium. This enhanced ability to metabolize metals may apply to other metals because nonsmokers had manganese, nickel, and chromium levels approximately twice those of smokers at the beginning of the workweek. For 1-OHP, smokers had higher levels compared with nonsmokers and this reflects the fact that cigarettes contain much PAH. We have shown previously that 1-OHP is a useful biomarker of PAH exposure in boilermakers exposed to ROFA, particularly in nonsmokers (13). Likely, the ability to metabolize metals and 1-OHP from occupational sources will be directly affected by smoking. This has major implications for workers who are exposed occupationally to metals and PAH and will modify levels of oxidative damage that occur in response to these agents.
Oxidative DNA Injury Biomarkers in Boilermakers
Our results demonstrate that nonsmoking boilermakers have higher urinary 8-OH-dG levels at the start of the workweek than boilermakers who are smokers. There are several explanations for this result that must be considered. Firstly, nonsmoking boilermakers may develop higher levels of oxidative DNA damage in response to occupational ROFA and metal fume exposure. Secondly, nonsmoking boilermakers may be exposed to significant causes of oxidative damage on the weekends (e.g., marathon running and exposure to environmental tobacco smoke in nightclubs) compared with smoking boilermakers. In this study, we did not ask specific questions on weekend activities; therefore, we are unable to confirm this explanation. Thirdly, they may have a greater capacity to repair damaged DNA compared with boilermakers who smoke. Another explanation may be that smoking boilermakers exhibit a down-regulation in their ability to repair and eliminate damaged DNA compared with nonsmokers. The decrease in 8-OH-dG levels in nonsmoking boilermakers during the workweek may indicate transient suppression in the ability to repair DNA that recovers during their off-work days. This would explain the higher levels of 8-OH-dG seen on day 1 preshift in nonsmoking boilermakers. In contrast, boilermakers who smoked showed minimal variation in 8-OH-dG levels across the workweek. These individuals may have developed a more sustained suppression due to the effect of smoking in conjunction with occupational exposures. In this study, we were unable to collect urine samples from boilermakers on their off-work days. In addition, it would have been helpful to measure biomarker levels in non-ROFA- and metal fume-exposed workers to determine what role occupational exposure has on biomarker levels in nonexposed individuals.
These results are in contrast to several studies, which show that smoking elevates the urinary excretion of 8-OH-dG by 1650% (3537). However, these studies were often of small size and did not use the repeated-measures study design but focused on single spot urine measurement or cross-week changes. These methods to measure urinary 8-OH-dG are unlikely to represent individual long-term excretion rates and do not allow for intraindividual variability of 8-OH-dG as in our study. In addition, a study by Pilger et al. (37) found that a significant increase in 8-OH-dG levels in smokers was observed in only two of six series after repeated sampling of the same individuals during a 6-month period.
Few epidemiologic studies have investigated oxidative injury biomarkers in an occupational setting, but most studies show an increase in 8-OH-dG levels (in leukocytes and urine) after exposure to toxic chemicals, including styrene (38), benzene (39), coal-tar pitch dust, and asphalt fume (18), rather than the initial decrease demonstrated in nonsmokers and the minimal cross-week change seen in boilermakers who smoke in our study. There are likely to be a few reasons to explain this difference. Firstly, it is likely that the exposures (metal and ROFA particulates) in our study have markedly different cellular and systemic effects compared with the above agents. Secondly, we used a repeated-measures study design with twice-daily urine sampling for an entire week. However, most studies measure urinary and blood biomarkers either at the beginning and end of a work shift or as a single measurement. These readings may be affected by the known circadian variation in 8-OH-dG levels (with lower levels recorded in the morning; 40) and by other factors [e.g., age, diet (41), and smoking status]. With repeated sampling, we were able to minimize these effects but not totally control for these other factors.
Decreased 8-OH-dG Levels Associated with Disease
Markedly reduced urinary 8-OH-dG levels have been identified in patients suffering from systemic lupus erythematosus compared with healthy controls and patients with rheumatoid arthritis (42). In that study, decreased 8-OH-dG levels were suggested to reflect an impaired ability of systemic lupus erythematosus lymphocytes to repair damaged DNA. Another study of patients with silicosis found that those with increased 8-OH-dG in DNA showed significantly lower urinary excretion of 8-OH-dG compared with quartz-exposed healthy workers (17). This result was suggested to reflect a shift in the balance between oxidative DNA damage and repair mechanisms in patients with silicosis. In our study, we did not measure leukocyte DNA levels of 8-OH-dG, but taken together with the results from these two studies and the urinary 8-OH-dG levels in our study, there may be reduced ability to eliminate ROFA- and metal fume-induced 8-OH-dG, particularly in smoking boilermakers.
Determinants of the 8-OH-dG Level
Finally, we demonstrate that interactions between workplace cotinine and metals (nickel, vanadium, chromium, and copper) are also significant determinants of the 8-OH-dG level and that the direction of the interaction effect varies depending on the metal. These differential effects (Table 3) depending on the metal and the interaction with cigarette smoking is intriguing and unexpected. However, it is known that various metals can cause differential effects at the cellular level (14). The transition metal constituents of ROFA, including vanadium, chromium, manganese, nickel, and copper have been shown to be capable of inducing oxidative stress at a cellular level (43). Some of these metals can catalyze Fenton-type reactions and lead to the generation of ROS (44).
In this study, 1-OHP x cotinine, manganese x cotinine, and lead x cotinine interactions were not significantly associated with 8-OH-dG levels. For the metal biomarkers, this suggests that there are differential effects of each metal and some metals are more significant overall in conjunction with smoking than others. The lack of association of the 1-OHP level with 8-OH-dG levels may be explained by the fact that oxidative stress may not be a major or significant component of PAH carcinogenesis or there may be a time lag between exposure (as measured by the levels of the urinary biomarker 1-OHP) and effect (as measured by the 8-OH-dG level). Future studies focusing on longitudinal changes in biological markers of oxidative injury and exposure may provide further information on the mechanisms involved in metal and PAH exposure causing injury and disease.
| Conclusions |
|---|
|
|
|---|
| Acknowledgments |
|---|
| Footnotes |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 6/11/03; revised 10/15/03; accepted 11/25/03.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M.-R. Chao, C.-J. Wang, M.-T. Wu, C.-H. Pan, C.-Y. Kuo, H.-J. Yang, L. W. Chang, and C.-W. Hu Repeated Measurements of Urinary Methylated/Oxidative DNA Lesions, Acute Toxicity, and Mutagenicity in Coke Oven Workers Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3381 - 3389. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Borthakur, C. Butryee, M. Stacewicz-Sapuntzakis, and P. E. Bowen Exfoliated Buccal Mucosa Cells as a Source of DNA to Study Oxidative Stress Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 212 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Iarmarcovai, I. Sari-Minodier, F. Chaspoul, C. Botta, M. De Meo, T. Orsiere, J.L. Berge-Lefranc, P. Gallice, and A. Botta Risk assessment of welders using analysis of eight metals by ICP-MS in blood and urine and DNA damage evaluation by the comet and micronucleus assays; influence of XRCC1 and XRCC3 polymorphisms Mutagenesis, November 1, 2005; 20(6): 425 - 432. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |